Is occupational exposure to solvents associated with an increased risk for developing systemic scleroderma?

Birgitta Kütting1, Wolfgang Uter2, Hans Drexler1
1Institute and outpatient clinic of occupational, social and environmental medicine (head: Prof. Dr. H. Drexler), University of Erlangen-Nuremberg, Erlangen, Germany
2Dept. of Medical Informatics, Biometry and Epidemiology (head: Prof. Dr. O. Gefeller), University of Erlangen-Nuremberg, Erlangen, Germany

Tóm tắt

Our study was aimed to investigate in a German collective if there are any hints for an increased occupational or environmental risk to develop systemic sclerosis, especially, focussing on work-related exposure to solvents. Moreover, we tried to evaluate the feasibility of a sampling method addressing support groups. A standardised questionnaire was published in two journals subscribed by members of two different support groups and all members were asked to complete the questionnaire and to return it anonymously. The subjects were not informed on the scientific hypotheses, nor did they know who of them belonged to the case group (scleroderma) or to the control group (multiple sclerosis). 175 questionnaires could be included in the statistical analysis. As expected, a female predominance was in our collective. In the male subpopulation, the occupational exposure to solvents was higher in the case group than in the control-group (70% versus 45.8%). Based only on the male subgroup, a tendency for an association between occupational exposure to solvents and the risk to develop systemic sclerosis was found. According to our experience in this case-control-study exposure misclassification, qualitative or quantitative, was an eminent problem. Within such a setting, it is generally very difficult to establish an exact dose-response relationship due to incomplete, imprecise or missing data concerning duration of exposure, frequency of use and kind of solvent. Additionally, a well-known problem in studies based on self-reported questionnaires is the so-called volunteer bias. Unfortunately, but similar to other studies assessing epidemiologic factors in such a rare disease, our study was of limited power, especially in the subgroups defined by gender.

Từ khóa


Tài liệu tham khảo

Pelmear PL, Roos JO, Maehle WM: Occupationally-induced scleroderma. J Occup Med 1992, 34: 20–25.

Bovenzi M, Barbone F, Betta A, Tommasini M, Versini W: Scleroderma and occupational exposure. Scand J Work Environ Health 1995, 21: 289–292.

Kütting B, Otto A, Drexler H: Systemische Sklerodermie bei beruflicher Exposition zu Lösemitteln – eine neue Berufskrankheit? [Systemic sclerosis and work-related exposure to solvents – a new occupational disease]. Dermatologie in Beruf und Umwelt 2004, 52: 1–8.

Cook NJ, Silman AJ, Propert J, Cawley MID: Features of systemic sclerosis in an identical twin pair. Br J Rheumatol 1993, 32: 926–928.

Faghali CA, Wright TM: epidemiological and clinical studies of twins with scleroderma. Arthritis Rheum 1995, 38: S308.

Silman AJ, Hochberg MC: Occupational and environmental influences on scleroderma. Rheum Dis Clin North Am 1996, 4: 737–747. 10.1016/S0889-857X(05)70298-2

Maddison PJ, Skinner RP, Pereira RS, Black CM, Ansell BM, Jayson MI, Rowel NR, Welsh KI: Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis. Ann Rheum Dis 1986, 45: 793–799.

McNeilage LJ, Youngchaiyud U, Whittigham S: Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma. Arthritis Rheum 1989, 32: 54–60.

Beebe JL, Lacey JB, Mayes MD, Gillespie BW, Cooper BC, Laing TJ, Schottenfeld D: Reproductive history, oral contraceptive use, oestrogen replacement therapy and the risk of developing of scleroderma. Arthritis Rheum 1997, 40: S100.

D'Cruz D: Autoimmune disease associated with drugs, chemicals and environmental factors. Toxicolology Letters 2000, 112–123: 421–432. 10.1016/S0378-4274(99)00220-9

Reinl W: Scleroderma caused by trichloroethylene in workers. Bull Hyg 1957, 32: 678.

Bottomley WW, Sheehan-Dare RA, Hughes P, Cunliffe WJ: A sclerodermatous syndrome with unusual features following prolonged occupational exposure to organic solvents. Br J Dermatol 1993, 128: 203–206.

Czirják L, Schlammadinger J, Szegedi G: Systemic sclerosis and exposure to trichloroethylene. Dermatology 1993, 186: 236.

Czirják L, Pócs E, Szegedi G: Localized scleroderma after exposure to organic solvents. Dermatology 1994, 189: 399–401.

Flindt-Hansen H, Isager H: Scleroderma after occupational exposure to trichlorethylene and Trichlorethane. Acta Derm Venereol [Stockh] 1987, 67: 263–264.

Waldner BK: Do solvents cause scleroderma? Int J Dermatol 1983,22(3):157–158.

Yamakage A, Ishikawa H: Generalized morphea-like scleroderma occurring in people exposed to organic solvents. Dermatologica 1982, 165: 186–193.

Aryal BK, Khuder SA, Schaub EA: Meta-Analysis of Systemic Sclerosis and exposure to solvents. Am J Ind Med 2001, 40: 271–274. 10.1002/ajim.1098

Diot E, Lesire V, Guilmot JL, Metzger MD, Pilore R, Rogier S, Stadler M, Diot P, Lemarie E, Lasfargues G: Systemic sclerosis and occupational risk factors: a case-control study. Occup Environ Med 2002,59(8):545–549. 10.1136/oem.59.8.545

Garabrant DH, Lacey JV, Laing TJ, Gillespie BW, Mayes MD, Cooper BC, Schottenfeld D: Scleroderma and solvent exposure among women. Am J Epidemiol 2003, 157: 493–500. 10.1093/aje/kwf223

Bovenzi M, Barbone F, Pisa FE, Betta A, Romeo L, Tonello A, Biasi D, Caramaschi P: A case control study of occupational exposures and systemic sclerosis. Int Arch Occup Environ Health 2004, 77: 10–16. 10.1007/s00420-003-0462-5

Silman AJ, Jones S: What is the contribution of occupational environmental factors to the occurrence of scleroderma in men? Ann Rheum Dis 1992, 51: 1322–1324.

Nietert PJ, Sutherland SE, Silver RM, Pandey JP, Knapp RG, Hoel DG, Dosemeci M: Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum 1998, 41: 1111–1118. 10.1002/1529-0131(199806)41:6<1111::AID-ART19>3.0.CO;2-J